impact factor
logo
 

Letters to the Editor

 

Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab


1, 2, 3

 

  1. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany. larissa.valormendez@uk-erlangen.de
  2. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany.
  3. Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Deutsches Zentrum für Immuntherapie (DZI) FAU Erlangen-Nürnberg and Universitätsklinikum Erlangen, Germany.

CER14634
2022 Vol.40, N°4
PI 0854, PF 0855
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 34796852 [PubMed]

Received: 15/03/2021
Accepted : 26/07/2021
In Press: 17/11/2021
Published: 04/05/2022

Rheumatology Article